- The Dish’s Weekly Biotechnology News Wrap Up – April 21, 2017Posted 4 days ago
- Glycosylation Overview and How to Control Glycosylation using In Vitro GlycoengineeringPosted 6 days ago
- A Novel Approach for Expansion of High Quality Mesenchymal Stem CellsPosted 7 days ago
- Cell Therapy Clinical Trials: Navigating the operational shift from Phase 1 to Phase 2Posted 1 week ago
- The Dish’s Weekly Biotechnology News Wrap Up – April 14, 2017Posted 2 weeks ago
- GMP Proteins for Cell Therapy Manufacturing: Top 6 Things to KnowPosted 2 weeks ago
- Smart Cell Culture Monitoring – Transforming the way we look at cells in culturePosted 2 weeks ago
- A Primer on Primary Cells and CulturePosted 2 weeks ago
- The Importance of Resin Selection in Development of a Platform Bioprocess FilmPosted 2 weeks ago
- The Dish’s Weekly Biotechnology News Wrap Up – April 7, 2017Posted 3 weeks ago
More Regulatory News
Reducing CGMP Compliance Challenges is Key to Public Vaccine Confidence and Industry Success
Last month the Food and Drug Administration (FDA) issued a warning letter to Sanofi...
- Posted August 8, 2012
The House Passes FDA User Fee Reauthorization Bill; Senate Next
On June 20th, the House passed the Food and Drug Administration (FDA) User Fee...
- Posted June 25, 2012
The Arduous Path to the Clinic – Plan Early to Avoid Late Attrition!
A Guest Blog by Michel Fischbach, Chief Scientific Officer, TNCBio Stem cell therapies (SCTs)...
- Posted June 20, 2012
FDA Issues Guidance for Warning Labels on All Drugs Produced Using Blood Products including Plasma-derived Albumin
When animal-derived or human-derived blood products are used in biomanufacturing there is always a...
- Posted June 13, 2012
Mad Cow Case: Animal Component Free is the Way Forward
The United States’ fourth case of mad cow disease (bovine spongiform encephalopathy) was discovered...
- Posted April 25, 2012